[
  {
    "ts": null,
    "headline": "Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment",
    "summary": "Zai Lab Ltd (NASDAQ:ZLAB) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On June 30, Leerink Partners raised its price target for the stock to $75 from $73. The research firm also reiterated an ‘Outperform’ rating on the stock. The research firm hiked its price target following positive Phase […]",
    "url": "https://finnhub.io/api/news?id=9f0def21bd00432699a44373b5f60a01a102d10c69c284134b6911b70cebabfb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753415278,
      "headline": "Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment",
      "id": 136085035,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Zai Lab Ltd (NASDAQ:ZLAB) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On June 30, Leerink Partners raised its price target for the stock to $75 from $73. The research firm also reiterated an ‘Outperform’ rating on the stock. The research firm hiked its price target following positive Phase […]",
      "url": "https://finnhub.io/api/news?id=9f0def21bd00432699a44373b5f60a01a102d10c69c284134b6911b70cebabfb"
    }
  }
]